{"name":"Thermo Fisher Scientific","slug":"thermo-fisher","ticker":"TMO","exchange":"NYSE","domain":"thermofisher.com","description":"Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).","hq":"Waltham, MA, USA","founded":0,"employees":"125000","ceo":"Marc N. Casper","sector":"Life Science Tools / Diagnostics / CRO-CDMO","stockPrice":453.07,"stockChange":7.04,"stockChangePercent":1.58,"marketCap":"$168.4B","metrics":{"revenue":45197000704,"revenueGrowth":6.2,"grossMargin":40.9,"rdSpend":1397000000,"netIncome":6704000000,"cash":3256000000,"dividendYield":0.39,"peRatio":24.9,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-01","type":"earnings","headline":"Thermo Fisher Scientific Reports Fourth-Quarter and Full-Year 2023 Results","summary":"Thermo Fisher Scientific reported fourth-quarter and full-year 2023 results, with revenue of $11.4 billion and adjusted EPS of $7.51.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Thermo Fisher Scientific Acquires PPD, Inc.","summary":"Thermo Fisher Scientific acquired PPD, Inc., a leading contract research organization (CRO), for $17.4 billion.","drugName":"","sentiment":"positive"},{"date":"2022-06-01","type":"regulatory","headline":"Thermo Fisher Scientific Receives FDA Clearance for New Instrument","summary":"Thermo Fisher Scientific received FDA clearance for a new instrument, expanding its product portfolio for life science research.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-03","type":"pipeline","source":"simplywall.st","summary":"Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Biotech Tools And Cryo TEM Launches - simplywall.st","headline":"Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Biotech Tools And Cryo TEM Launches","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOYXZMZThGSFh0d1lQVXlsbVZfS1RBSHlaX0tiZDVNQXdDN3JPNWNFY3BqQ1hIYVFnanpFMGkyVnRyUXBsbjN3YmU4dVR6SXduQ0VLd2ZybDctTnBVa0lwUUV0ZVkwTjMwejlKblZ3dW9vTjE1TXAwNjV2WTBBTkRjTkRZa1hnbXFfZEFsMGp4Si10NkdOTkhuOS1yNFJZS1NkN1VpU0NzN2xmT2psX2FnT3AySlpiZGVSQVdfX3piOENQS2lvZVppM2lFQVFBQjk2WkJLSk5OT3AxdHdQX1lPTnF2VHdPSWNoRHRB0gHwAUFVX3lxTFB0X2NrdkFubmhJVEtjY240MXlyeWYyQnZDZWUxRXVYelU1RWJLY0kwLVdUNXFvdEJISy1IZ2VIQmY1bDhqUWw0TUNvckFPX05SS2ZNUzh2R3J5eGtrYXpKTnU2ZlRiVWtrMUVNSEdlMTdIbHZGZmc2bjZXblBrTGYweHo5UmVnOXVvTmtIQjZOc3JrSUx4OS1Gbkg4N0VlUE84UnJ5OFk5QVZiTk90aWRYT3BLa1VYeE0zSXo2akpNUTYxQk9yWUxiaW9WUzJFZ3VhckdVVHJfSGVJRmpXcXFUUGdPU283SlQtWnFieWVmWg?oc=5","date":"2026-04-01","type":"pipeline","source":"simplywall.st","summary":"Thermo Fisher’s Glacios 3 Cryo TEM Puts AI At Center Of Growth - simplywall.st","headline":"Thermo Fisher’s Glacios 3 Cryo TEM Puts AI At Center Of Growth","sentiment":"neutral"},{"date":"2026-03-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNbEhNa3JNVC1kaE5MTklJT3BMd2pQSGlLVGNkTFhNamFyRkRsUUVDSVVzN1BFelM0UVpZZkZyTGxzTlVxV09MeGZPM01SV2NUeVJROUl1Y1FkQUlwQVFnQ3BNRVNzVzRKRHJBUHR3aFBnMnhsUWctdEppMlJoYm9iUmR0aWZpeXZldktlUGhUV3dTd1M0aHhWZGhOWk41eW9PaENSR25NMloxY3ctMW04VGNlZE4zR0NZZFhfZXNIc3dVQQ?oc=5","date":"2026-03-06","type":"pipeline","source":"TradingView","summary":"Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio? - TradingView","headline":"Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNTlp0clRjSkh6WlhQV1dra3dtYl9LQWRSTUlVVjRCWWhtMWN4eEdiUkh0WWxidGQ4QTFlWHlZZm16VkxJdXZjbm01VEV6Ykx2MVVoekdyQXo3QUVwR0YzYWU1b1ItRWtrSE1OSmYwYURHcUdrREV1bkpGbDdzYklfV180MUZoZk02MnhSX1JWUmlvSlFWSWFHeXZ3SlBjWFkzVFVJ?oc=5","date":"2026-03-02","type":"pipeline","source":"Seeking Alpha","summary":"Thermo Fisher Scientific: Recovery In Life Sciences Solutions (NYSE:TMO) - Seeking Alpha","headline":"Thermo Fisher Scientific: Recovery In Life Sciences Solutions (NYSE:TMO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPaGZaNkU3NmJpWjNWenRjVjFIMXdsM2p5WWNrNVhMeGl4cDVCb3FiXzFMc0NKRU9ObzhDeFIwajBMQUd2UFNMbnZhSmJRamVJTzdPNTRtQ1N6NHNNeDlmQU5BeWtHVjk2UmFxcmNtYXk1cmpxSTVVZHVNZUFIV2FGaEZBcjVael9oZEd1V1lQcVFjUkF4WnJlVnpvbFhqbU1QdVRzdFJJZUJnVFQ4bmZvVkR5T3A4cV9UNDZwUUgxa3A4akFaaFAwNUYzMFM2UU1TWkl1Zk1wdHBmeUVUX0wyZQ?oc=5","date":"2026-01-29","type":"earnings","source":"Reuters","summary":"Thermo Fisher forecasts 2026 profit below estimates on research funding cuts - Reuters","headline":"Thermo Fisher forecasts 2026 profit below estimates on research funding cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxORGxLSGtXRTFWcVh3LXZ3c1Q1U3oyMnVIQ0pjOWdnLWF0bUhQY0p6MXFDMGFnejY1a3FvdWVCZEUzSFZxVzZLSUN3MVMxUXNpU2RFUzUxYWpta3ktYUpIcWpvVVB1VW5PWjNhMG0zcEJRNG5XSDNSWlYycHVvVGg1VzFNVHhsU3dwZ193Tko5UjdJLWd4elJtTkExNExaclNTN1JGdmRkQVNxOEZtZXlMNTBKVFJTcThGeWJzTll1UTZLdXhWTEVOLURtQ3h3cjcwa0ZZ?oc=5","date":"2026-01-13","type":"pipeline","source":"Reuters","summary":"Thermo Fisher wins contracts as pharma shifts production to US, CEO says - Reuters","headline":"Thermo Fisher wins contracts as pharma shifts production to US, CEO says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNODhyV2Q5ZzNYUURjcHZZVFlremFuWUVHTFp0NUd1aVVfUm1Cc0lmMmduYUZEUFlfeUVPVUU2Ni1vbWFRYjdja2RQNS04NmdZOEZzQUdtQm1wYTR4M01CeTVqN21kOUNlT09aUkdCTnpIRlRjaGFTNlpMQ2F5d28xWHkwVHlqNDhn?oc=5","date":"2026-01-05","type":"regulatory","source":"Yahoo Finance","summary":"Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)? - Yahoo Finance","headline":"Will Thermo Fisher’s Pharma Demand Outlook and Clario Deal Reframe Its Investment Story (TMO)?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbHZfZllnNWZOMWh3cGhDaThtNkRkcFFfbFA5a1pXdFRZWFQxTkFRRzJsU3U2Mzd0c0FtbWI1LWtNWkRmVEJnOU9HVWgxZEdBUjhQWjdWa2lCUWhtNngyZ2NWa19UNDZaajlFcDViQktpWEx0U1FnbGpYWWl2dDVWMjNFMEhaUHNiNDZzY2gtU0czZk1QOUhPMGJoeGFYbDdGcEw5QjhubWVuR2JhdF85Zk9TWkpibi1R?oc=5","date":"2025-11-02","type":"trial","source":"MedCity News","summary":"Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario - MedCity News","headline":"Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOMVhkTmxpVGpweUExdElfQ1YxNXVhb0xMaFpwYXBWRjRib2lRY2pyRGN2ZlpOeWt5WGY0eTd2TVM2LUk2SFZpbm84TTA4YTA0UTFBc3VXSW9CSDZTeVNIb3NXbEhLd3VGVnlfZEhpNndGLU1hTDRJVDlWTkVQU0p6WGJJbVZ4c2xmWGVzMDh3cEM2LVFvdTctVVdoR1BQOTNaUUctb25UX20xY0dD?oc=5","date":"2025-10-29","type":"deal","source":"citybiz","summary":"Thermo Fisher Scientific to Acquire Clario Holdings For $8.875 Billion - citybiz","headline":"Thermo Fisher Scientific to Acquire Clario Holdings For $8.875 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQWFl6RF9udXJwSWdCelpYcmZMSVBsQjM1MkZEZ2hhX2F3RVg1cXd6Wl9QWHhCZk1LUWdYQnhkWFMxQ3hya2NpWWp4d0ZRUndvMEFKci1mZ2oxZ0hubXNhQUUwNXpodXBpYnoyVGVSc2dsRXpscXNDR1YxMER2VURCeWgzMVJKZExMcUpiNXJ0TjkxQjQ5bExKdWNxY2tQZjI2b19EQmtjRVBlcWpKU2hacWtR?oc=5","date":"2025-09-02","type":"deal","source":"Stock Titan","summary":"Major Manufacturing Expansion: Thermo Fisher Acquires Sanofi's NJ Facility, Adds 200 Expert Staff - Stock Titan","headline":"Major Manufacturing Expansion: Thermo Fisher Acquires Sanofi's NJ Facility, Adds 200 Expert Staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNWm1vUU83RHpuUGJHSkZJbmxYRW53UWh0ak0yWE9XcXlHSEZpaXJBRGhZRWhERDROUVpCY2FzVUUtZG01dDUzbF95MEV2cDRmZzYxM3IweFRWU3ZXV0staVJJcFloeTJWWTNOLTRrQlNmdWJ5ZW1VNFdKQ0VueEtTcG1zTXZfT09pUVNnVTBuSEJjbEZWUHNuZDAyZXJodFJQSl9hSTZIVk5UdmZVUkFRYlNpbjRVcUY1U2xaVA?oc=5","date":"2025-07-16","type":"pipeline","source":"Fierce Pharma","summary":"Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase - Fierce Pharma","headline":"Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQT3N6d0xfNU8xaFQyeXFNbTFuc2FOaDBKZmFzdTItNnB1TEs2X2o0OWZQdnV4QjZvRzBpSC1fLV9haFpDd3VNRVJBa3oxOGttYkx6cFRDVFBOV3RhSjZhR0JFbzUzQ1hvRXl3cGo3ajJNQkhfYV9RU2JqbDFrc05LSWlFam0xdw?oc=5","date":"2025-07-15","type":"deal","source":"Yahoo Finance","summary":"Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - Yahoo Finance","headline":"Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Agilent Technologies","Danaher Corporation","PerkinElmer, Inc."],"therapeuticFocus":["Life Science Research","Diagnostics"],"financials":{"source":"sec_edgar+yahoo","revenue":20918000000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":20918000000,"period":"2017-12-31"},{"value":6047000000,"period":"2017-12-31"},{"value":5116000000,"period":"2017-09-30"},{"value":4990000000,"period":"2017-07-01"},{"value":4765000000,"period":"2017-04-01"}],"grossProfit":18239000000,"grossProfitHistory":[{"period":"2025-12-31","value":18239000000},{"period":"2024-12-31","value":17702000000},{"period":"2023-12-31","value":17100000000},{"period":"2022-12-31","value":18971000000}],"rdSpend":1397000000,"rdSpendHistory":[{"period":"2025-12-31","value":1397000000},{"period":"2024-12-31","value":1390000000},{"period":"2023-12-31","value":1337000000},{"period":"2022-12-31","value":1471000000}],"sgaSpend":8732000000,"operatingIncome":8110000000,"operatingIncomeHistory":[{"period":"2025-12-31","value":8110000000},{"period":"2024-12-31","value":7717000000},{"period":"2023-12-31","value":7318000000},{"period":"2022-12-31","value":8507000000}],"netIncome":6704000000,"netIncomeHistory":[{"period":"2025-12-31","value":6704000000},{"period":"2024-12-31","value":6335000000},{"period":"2023-12-31","value":5995000000},{"period":"2022-12-31","value":6950000000}],"eps":17.74,"epsHistory":[{"period":"2025-12-31","value":17.74},{"period":"2024-12-31","value":16.53},{"period":"2023-12-31","value":15.45},{"period":"2022-12-31","value":17.63}],"cash":9852000000,"cashHistory":[{"period":"2025-12-31","value":9852000000},{"period":"2024-12-31","value":4009000000},{"period":"2023-12-31","value":8077000000},{"period":"2022-12-31","value":8524000000}],"totalAssets":110343000000,"totalLiabilities":56807000000,"totalDebt":39385000000,"equity":53407000000,"operatingCashflow":7818000000,"operatingCashflowHistory":[{"period":"2025-12-31","value":7818000000},{"period":"2024-12-31","value":8667000000},{"period":"2023-12-31","value":8406000000},{"period":"2022-12-31","value":9154000000}],"capex":-1525000000,"capexHistory":[{"period":"2025-12-31","value":-1525000000},{"period":"2024-12-31","value":-1400000000},{"period":"2023-12-31","value":-1479000000},{"period":"2022-12-31","value":-2243000000}],"freeCashflow":6293000000,"dividendsPaid":-636000000,"buybacks":-3000000000,"employees":125000,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":2181000000,"ebit":2088000000,"ebitda":2824000000,"period":"2026-03-31","revenue":11005000000,"epsBasic":4.44,"netIncome":1651000000,"rdExpense":336000000,"epsDiluted":4.43,"grossProfit":4430000000,"operatingIncome":1913000000},{"sga":2352000000,"ebit":2518000000,"ebitda":3246000000,"period":"2025-12-31","revenue":12215000000,"epsBasic":5.22,"netIncome":1964000000,"rdExpense":356000000,"epsDiluted":5.21,"grossProfit":5011000000,"operatingIncome":2303000000},{"sga":2162000000,"ebit":2173000000,"ebitda":2834000000,"period":"2025-09-30","revenue":11122000000,"epsBasic":4.28,"netIncome":1616000000,"rdExpense":346000000,"epsDiluted":4.27,"grossProfit":4583000000,"operatingIncome":2075000000},{"sga":2140000000,"ebit":2113000000,"ebitda":2799000000,"period":"2025-06-30","revenue":10854000000,"epsBasic":4.28,"netIncome":1617000000,"rdExpense":352000000,"epsDiluted":4.28,"grossProfit":4408000000,"operatingIncome":1916000000},{"sga":2078000000,"ebit":1923000000,"ebitda":2628000000,"period":"2025-03-31","revenue":10364000000,"epsBasic":3.99,"netIncome":1507000000,"rdExpense":342000000,"epsDiluted":3.98,"grossProfit":4235000000,"operatingIncome":1815000000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":453.07,"previousClose":446.03,"fiftyTwoWeekHigh":643.99,"fiftyTwoWeekLow":385.46,"fiftyTwoWeekRange":"385.46 - 643.99","fiftyDayAverage":487.15,"twoHundredDayAverage":527.37,"beta":0.88,"enterpriseValue":205787316224,"forwardPE":16.6,"priceToBook":3.19,"priceToSales":3.73,"enterpriseToRevenue":4.55,"enterpriseToEbitda":18.22,"pegRatio":1.53,"ebitda":11296000000,"ebitdaMargin":25,"freeCashflow":5520625152,"operatingCashflow":8287000064,"totalDebt":43161001984,"debtToEquity":82.9,"currentRatio":1.53,"returnOnAssets":5,"returnOnEquity":13.5,"analystRating":"1.3 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":0,"targetMeanPrice":617.62,"targetHighPrice":0,"targetLowPrice":0,"dividendRate":1.76,"payoutRatio":0.1,"fiveYearAvgDividendYield":0.25,"exDividendDate":1773360000,"insiderHeldPercent":0.2,"institutionHeldPercent":94.7,"sharesOutstanding":371621465,"floatShares":370688695,"sharesShort":4865972,"shortRatio":2.43,"shortPercentOfFloat":1.3,"epsTrailing":18.2,"epsForward":27.33,"revenuePerShare":120.36,"bookValue":141.96,"officers":[{"age":57,"name":"Mr. Marc N. Casper","title":"Chairman & CEO"},{"age":46,"name":"Mr. Gianluca  Pettiti","title":"President, COO & President of Products and Technologies"},{"age":45,"name":"Mr. James R. Meyer","title":"Senior VP & CFO"},{"age":45,"name":"Mr. Joseph R. Holmes","title":"VP & Chief Accounting Officer"},{"age":null,"name":"Mr. Ryan J. Snyder","title":"Senior VP & Chief Information Officer"},{"age":null,"name":"Dr. Karen E. Nelson Ph.D.","title":"Chief Scientific Officer"},{"age":null,"name":"Mr. Rafael  Tejada","title":"Vice President of Investor Relations"},{"age":null,"name":"Mr. Thomas Bailey Shropshire Jr.","title":"Senior VP and General Counsel"}],"industry":"Diagnostics & Research","irWebsite":"http://ir.thermofisher.com/phoenix.zhtml?c=89145&p=irol-IRHome","website":"https://www.thermofisher.com","phone":"781 622 1000"}}